-
EP2402021
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2402021
| EP2402021 - Pharmaceutical composition for treating or relieving inflammatory bowel disease [Right-click to bookmark this link] | |||
| Former [2012/01] | Pharmaceutical composition for treating or releiving inflammatory bowel disease | ||
| [2012/17] | Status | The application is deemed to be withdrawn Status updated on 01.02.2019 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 27.03.2018 | Most recent event Tooltip | 01.02.2019 | Application deemed to be withdrawn | published on 06.03.2019 [2019/10] | Applicant(s) | For all designated states Industrial Technology Research Institute No. 195, Sec. 4, Chung Hsing Road Chutung, Hsinchu 310 / TW | [2012/01] | Inventor(s) | 01 /
Shih, Ying-Chu 12F., No. 28, Liujia 6th St. Zhubei City 302 Hsinchu County / TW | 02 /
Lee, Lain-Tze No. 137, Simen St. East Dist. 300 Hsinchu City / TW | 03 /
Hu, Nai-Yun No. 274, Datong Rd. Douliu City 640 Yunlin County / TW | 04 /
Tong, Tien-Soung No. 138, Futen 1st Street, South District 400 Taichung City / TW | [2012/01] | Representative(s) | Michalski Hüttermann & Partner Patentanwälte mbB Kaistraße 16A 40221 Düsseldorf / DE | [N/P] |
| Former [2012/01] | Michalski Hüttermann & Partner Patentanwälte Neuer Zollhof 2 40221 Düsseldorf / DE | Application number, filing date | 11171756.7 | 28.06.2011 | [2012/01] | Priority number, date | US20100360190P | 30.06.2010 Original published format: US 360190 P | TW20100143928 | 15.12.2010 Original published format: TW 99143928 | US201113118413 | 28.05.2011 Original published format: US201113118413 | [2013/13] |
| Former [2012/01] | US20100360190P | 30.06.2010 | |
| TW20100143928 | 15.12.2010 | ||
| US20110118413 | 28.05.2011 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2402021 | Date: | 04.01.2012 | Language: | EN | [2012/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.10.2011 | Classification | IPC: | A61K36/233, A61P1/04 | [2012/01] | CPC: |
A61K36/233 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P29/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/01] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Pharmazeutische Zusammensetzung zur Behandlung oder Linderung von entzündlicher Darmerkrankung | [2012/01] | English: | Pharmaceutical composition for treating or relieving inflammatory bowel disease | [2012/17] | French: | Composition pharmaceutique pour traiter ou soulager les maladies intestinales inflammatoires | [2012/01] |
| Former [2012/01] | Pharmaceutical composition for treating or releiving inflammatory bowel disease | Examination procedure | 09.02.2012 | Amendment by applicant (claims and/or description) | 09.02.2012 | Examination requested [2012/13] | 16.02.2016 | Despatch of a communication from the examining division (Time limit: M06) | 04.08.2016 | Reply to a communication from the examining division | 21.03.2018 | Despatch of a communication from the examining division (Time limit: M06) | 02.10.2018 | Application deemed to be withdrawn, date of legal effect [2019/10] | 29.10.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/10] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.02.2016 | Fees paid | Renewal fee | 28.06.2013 | Renewal fee patent year 03 | 31.03.2014 | Renewal fee patent year 04 | 31.03.2015 | Renewal fee patent year 05 | 30.03.2016 | Renewal fee patent year 06 | 26.04.2017 | Renewal fee patent year 07 | 25.04.2018 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP0968718 (TEIKOKU SEIYAKU KK [JP]) [X] 1-15 * paragraphs [0020] , [0030]; example 2; claim -; table 2 *; | [X]CN101288744 ; | [T]CN102106884 | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2009, no. 09, Database accession no. 2009-B33755, XP002660540 & CN101288744 A 20081022 (TIANKE RENXIANG TECHNOLOGICAL BEIJING CO LTD) [X] 1-15 * abstract * | [I] - P. BREMNER ET AL, "Phenylpropanoid NF-[kappa]B inhibitors from Bupleurum fruticosum", PLANTA MEDICA, (20041001), vol. 70, no. 10, doi:10.1055/s-2004-832616, ISSN 0032-0943, pages 914 - 918, XP055008711 [I] 1-15 * the whole document * DOI: http://dx.doi.org/10.1055/s-2004-832616 | [T] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2011, no. 58, Database accession no. 2011-J94181, XP002660541 & CN102106884 A 20110629 (IND TECHNOLOGY RES INST TAIWAN) [T] * abstract * | by applicant | - The English-Chinese Encyclopedia of Practical Traditional Chinese medicine vol.2: The Chinese Materia Medica, HIGHER EDUCATION PRESS, (1994), page 78 | - CURRENT PROTOCOLS IN IMMUNOLOGY, (2001), pages 15.19.1 - 15.19.14 | - LAHAT G, HALPERIN D, FABIAN I ET AL., "Immunomodulatory Effects of Ciprofloxacin in TNBS-Induced Colitis in Mice", INFLAMM BOWEL DIS, (2007), vol. 13, doi:doi:10.1002/ibd.20077, pages 557 - 565, XP055452410 DOI: http://dx.doi.org/10.1002/ibd.20077 | - HOVE T, VAN DEN BLINK B, PRONK I ET AL., "Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.", GUT, (2002), vol. 50, pages 507 - 512, XP002605793 | - BOUMA G, STROBER W., "The Immunological and Genetic Basis of Inflammatory Bowel Disease", NATURE REVIEW IMMUNOLOGY, (2003), vol. 3, doi:doi:10.1038/nri1132, pages 521 - 533, XP009022981 DOI: http://dx.doi.org/10.1038/nri1132 | - HOVE T, VAN DEN BLINK B, PRONK I ET AL., "Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis", GUT, (2002), vol. 50, pages 507 - 512, XP002605793 | US20100829357 |